Profound Medical Corp.

TSX:PRN 株式レポート

時価総額：CA$285.0m

このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Profound Medical マネジメント

マネジメント 基準チェック /44

Profound Medical'sの CEO はArun Menawatで、 Aug2016年に任命され、 の在任期間は 7.83年です。 の年間総報酬は$ 889.95Kで、 41.6%給与と58.4%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の1.89%を直接所有しており、その価値はCA$ 5.38M 。経営陣と取締役会の平均在任期間はそれぞれ2.1年と4.8年です。

主要情報

Arun Menawat

最高経営責任者

US$889.9k

報酬総額

CEO給与比率41.6%
CEO在任期間7.8yrs
CEOの所有権1.9%
経営陣の平均在職期間2.1yrs
取締役会の平均在任期間4.8yrs

経営陣の近況

Recent updates

Does Profound Medical (TSE:PRN) Have A Healthy Balance Sheet?

May 03
Does Profound Medical (TSE:PRN) Have A Healthy Balance Sheet?

Is Profound Medical (TSE:PRN) Using Debt In A Risky Way?

Sep 15
Is Profound Medical (TSE:PRN) Using Debt In A Risky Way?

Will Profound Medical (TSE:PRN) Spend Its Cash Wisely?

Sep 07
Will Profound Medical (TSE:PRN) Spend Its Cash Wisely?

Here's Why We're Not Too Worried About Profound Medical's (TSE:PRN) Cash Burn Situation

Jan 07
Here's Why We're Not Too Worried About Profound Medical's (TSE:PRN) Cash Burn Situation

We Think Profound Medical (TSE:PRN) Can Easily Afford To Drive Business Growth

Jul 02
We Think Profound Medical (TSE:PRN) Can Easily Afford To Drive Business Growth

We Take A Look At Why Profound Medical Corp.'s (TSE:PRN) CEO Compensation Is Well Earned

May 13
We Take A Look At Why Profound Medical Corp.'s (TSE:PRN) CEO Compensation Is Well Earned

Analysts Expect Breakeven For Profound Medical Corp. (TSE:PRN) Before Long

May 07
Analysts Expect Breakeven For Profound Medical Corp. (TSE:PRN) Before Long

We Think Profound Medical (TSE:PRN) Can Afford To Drive Business Growth

Mar 25
We Think Profound Medical (TSE:PRN) Can Afford To Drive Business Growth

How Many Profound Medical Corp. (TSE:PRN) Shares Do Institutions Own?

Mar 04
How Many Profound Medical Corp. (TSE:PRN) Shares Do Institutions Own?

Profound Medical Corp. (TSE:PRN) Is Expected To Breakeven In The Near Future

Jan 27
Profound Medical Corp. (TSE:PRN) Is Expected To Breakeven In The Near Future

CEO報酬分析

Profound Medical の収益と比較して、Arun Menawat の報酬はどのように変化したか？
日付総報酬給与会社業績
Mar 31 2024n/an/a

-US$28m

Dec 31 2023US$890kUS$370k

-US$29m

Sep 30 2023n/an/a

-US$29m

Jun 30 2023n/an/a

-US$29m

Mar 31 2023n/an/a

-US$27m

Dec 31 2022US$916kUS$344k

-US$29m

Sep 30 2022n/an/a

-US$29m

Jun 30 2022n/an/a

-US$30m

Mar 31 2022n/an/a

-US$31m

Dec 31 2021US$4mUS$481k

-US$31m

Sep 30 2021n/an/a

-US$28m

Jun 30 2021n/an/a

-US$28m

Mar 31 2021n/an/a

-US$26m

Dec 31 2020US$2mUS$1m

-US$22m

Sep 30 2020n/an/a

-US$18m

Jun 30 2020n/an/a

-US$17m

Mar 31 2020n/an/a

-US$16m

Dec 31 2019US$2mUS$531k

-US$15m

Sep 30 2019n/an/a

-US$15m

Jun 30 2019n/an/a

-US$14m

Mar 31 2019n/an/a

-US$14m

Dec 31 2018US$672kUS$509k

-US$15m

Sep 30 2018n/an/a

-US$16m

Jun 30 2018n/an/a

-US$16m

Mar 31 2018n/an/a

-US$15m

Dec 31 2017US$264kUS$264k

-US$15m

報酬と市場: Arunの 総報酬 ($USD 889.95K ) は、 Canadian市場 ($USD 787.08K ) の同様の規模の企業の平均とほぼ同じです。

報酬と収益: Arunの報酬は、過去 1 年間の会社の業績と一致しています。

CEO（最高経営責任者

Arun Menawat (69 yo)

7.8yrs

在職期間

US$889,948

報酬

Dr. Arun Swarup Menawat, Ph D., MBA, served as the Chairman at Firefly Neuroscience, Inc. and is its Director. He serves as the Chairman at Profound Medical Corp. Dr. Menawat has been the Chief Executive O...

リーダーシップ・チーム

名称ポジション在職期間報酬所有権
Arun Menawat
Chairman of the Board & CEO7.8yrsUS$889.95k1.89%
$ 5.4m
Rashed Dewan
Chief Financial Officer3.1yrsUS$669.26k0.097%
$ 276.4k
Mathieu Burtnyk
Chief Operating Officerless than a yearUS$396.81k0.055%
$ 157.7k
Hartmut Warnken
Chief Commercial Officer of Outside US1.8yrsUS$226.17k0.0039%
$ 11.1k
Abbey Goodman
Chief Commercial Officer of US1.8yrsUS$555.98k0%
$ 0
Stephen Kilmer
Investor Relationsno dataデータなしデータなし
Jacques Cornet
Senior VP & Product Leader Sonalleve2.4yrsデータなしデータなし
Matthew Sobczyk
Assistant Corporate Controllerno dataデータなしデータなし
Levant Tinaz
Software Developerno dataデータなしデータなし

2.1yrs

平均在職期間

53.5yo

平均年齢

経験豊富な経営陣: PRNの経営陣は 経験豊富 であると考えられます ( 2.1年の平均在職年数)。

取締役

名称ポジション在職期間報酬所有権
Arun Menawat
Chairman of the Board & CEO9yrsUS$889.95k1.89%
$ 5.4m
Arthur L. Rosenthal
Independent Director6yrsUS$101.96k0.071%
$ 201.4k
Brian Ellacott
Independent Lead Director6yrsUS$102.91k0.28%
$ 791.5k
Cynthia Lavoie
Independent Director3.3yrsUS$97.91k0.025%
$ 69.8k
Mark Emberton
Member of Clinical Advisory Boardno dataデータなしデータなし
Murielle Lortie
Independent Director3.6yrsUS$100.41k0.013%
$ 36.7k
Eric Klein
Member of Clinical Advisory Boardno dataデータなしデータなし
Laurence Klotz
Member of Clinical Advisory Board1.7yrsデータなしデータなし
Scott Eggener
Member of Clinical Advisory Boardno dataデータなしデータなし
Adam Kibel
Member of Clinical Advisory Boardno dataデータなしデータなし
Aytekin Oto
Member of Clinical Advisory Boardno dataデータなしデータなし
Ian Thompson
Member of Clinical Advisory Boardno dataデータなしデータなし

4.8yrs

平均在職期間

67yo

平均年齢

経験豊富なボード: PRNの 取締役会 は 経験豊富 であると考えられます ( 4.8年の平均在任期間)。